Showing 1691-1700 of 1922 results for "".
- Novel Imaging Technology Reveals Role of Immune Cells in Early Diabetic Cataract Developmenthttps://modernod.com/news/novel-imaging-technology-reveals-role-of-immune-cells-in-early-diabetic-cataract-development/2481420/Novel findings from researchers contradict previous notions about sugar's role in the onset of diabetic cataracts. The team of researchers, led by Prof. Ali Hafezi-Moghadam, MD, PhD, Director of the Molecular Biomarkers Nano-Imaging Laboratory (MBNI) at the Brigham and Wom
- Research Challenges “Sugar Hypothesis” of Diabetic Cataract Developmenthttps://modernod.com/news/research-challenges-sugar-hypothesis-of-diabetic-cataract-development/2481371/New findings from investigators at Brigham and Women’s Hospital, a founding member of the Mass General Brigham health care system, contradict previous notions about sugar’s role i
- Outlook Therapeutics Closes $55 Million Financing; Extends Cash Runway Through Anticipated FDA Approval of ONS-5010https://modernod.com/news/outlook-therapeutics-closes-55-million-financing-extends-cash-runway-through-anticipated-fda-approval-of-ons-5010/2481313/Outlook Therapeutics announced it closed on approximately $25 million registered direct equity offering, and about $30 million net proceeds from issuance of an unsecured convertible promissory note with an initial conversion price of $2. The $50 million net proc
- Alcon Completes Acquisition of Aerie Pharmaceuticalshttps://modernod.com/news/alcon-completes-acquisition-of-aerie-pharmaceuticals/2481258/Alcon announced that it has completed its acquisition of Aerie Pharmaceuticals. In August, Alcon announced its was acquiring Aerie for about $770 million, or $15.25 per share—a premium of 37% to Aerie’s closing price prior to the deal. The deal bolsters Alcon's
- UCI Team Demonstrates the Adult Brain has the Potential to Partially Recover from Inherited Blindnesshttps://modernod.com/news/uci-team-demonstrates-the-adult-brain-has-the-potential-to-partially-recover-from-inherited-blindness/2481173/A discovery about how some visually impaired adults could start to see offers a new vision of the brain’s possibilities. The finding that the adult brain has the potential to partially recover from inherited blindness comes from a
- Alcon to Acquire Aerie Pharmaceuticalshttps://modernod.com/news/alcon-to-acquire-aerie-pharmaceuticals/2481041/In another move to bolster its glaucoma portolio and expand its pharmaceutical offerings, Alcon announced it is acquiring Aerie Pharmaceuticals for about $770 million, or $15.25 per share—a premium of 37% to Aerie’s lastest closing price. The transaction was a
- Kala Pharmaceuticals Launches Its First Direct-to-Consumer Campaign to Increase Awareness of Dry Eye Flareshttps://modernod.com/news/kala-pharmaceuticals-launches-its-first-direct-to-consumer-campaign-to-increase-awareness-of-dry-eye-flares/2480850/Kala Pharmaceuticals, Inc. today announced the launch of its first direct-to-consumer (DTC) campaign, “There for the Flare.” The campaign leverages digital channels to educate patients about dry eye flares and EYSUVIS® (loteprednol etabonate ophthalmic suspension 0.25%) and encour
- Zeiss Announces FDA Clearance of the Quatera 700 Phaco Devicehttps://modernod.com/news/zeiss-announces-fda-clearance-of-the-quatera-700-phaco-technology/2480779/Zeiss announced that the FDA has cleared the Quatera 700, which includes the Zeiss patented Quattro Pump designed to deliver chamber stability independent of IOP and flow. “What excites me the most about the Quatera 700 is the Quattro pump’
- Oculus Supports IMI in Raising Myopia Awarenesshttps://modernod.com/news/oculus-supports-imi-in-raising-myopia-awareness/2479430/Oculus has joined the International Myopia Institute (IMI) in tackling myopia awareness and will support the IMI activities to advance the research of myopia to prevent future vision impairment and blindness. “We are delighted about the cooperation. Our mission at Oculus is to support eye
- Hi-Health Announces Elevated Quality Process for Vista Advanced Supplementshttps://modernod.com/news/hi-health-announces-elevated-quality-process-for-vista-advanced-supplements/2479392/Hi-Health’s eye care brand, Vista OTC, is manufactured in cGMP certified and FDA regulated facilities. Hi-Health released a news release providing additional information about its quality standar